Delfi Diagnostics Enters into Broad Research Agreement with Top U.S. Cancer Center

Published on :

Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection, has entered into a broad research agreement with Memorial Sloan Kettering Cancer Center’s Biomarker Development Program, led by Howard I. Scher, MD, FASCO. The agreement creates a framework for Delfi and MSK researchers to work together on a range of projects studying Delfi’s liquid biopsy platform, advancing their shared mission of developing high performing cancer testing.

4 Baltimore Companies Driving Cancer Screening Technologies

Published on :

The cancer diagnostics market is surging, with an overall revenue growth expectation of hundreds of billions of dollars within the next eight years. The market is expected to grow to $257 billion by 2030, more than double the $124.9 billion valuation in 2021.

Life Science Development Projects Position Baltimore BioMed Ecosystem for Boom

Published on :

The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.

Meet Your 2021 BioBuzz Award Winners

Orange banner with photos of people, with text saying "2nd Annual BioBuzz Awards - Presenting Your Winners"
Published on :

Today, we are excited to announce the winners of our 2nd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.

2021 BioBuzz Awards Finalists

Published on :

We’re excited to announce this year’s finalists for the second annual 2021 BioBuzz Awards. These awards celebrate the people and companies across our regional community and their efforts and accomplishments to impact human health and build a stronger biotech community.